Physician profile
Daniel Ray Nelson
NPI 1235299819
$1,357.60
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $227 · 2021: $309 · 2022: $193.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.20 | 2019-2022 | |
| Amgen INC. | $234.02 | 2019-2022 | |
| Astellas Pharma US INC | $131.06 | 2019-2021 | |
| Daiichi Sankyo INC. | $108.20 | 2019-2022 | |
| Evofem Biosciences, INC. | $76.85 | 2021-2022 | |
| Coopersurgical, INC. | $65.99 | 2019-2021 | |
| Lupin INC. | $42.65 | 2019 | |
| Hologic Sales and Service, LLC | $41.41 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.34 | 2019-2020 | |
| Lsi Solutions INC | $37.17 | 2021 | |
| Meditrina | $35.71 | 2019-2022 | |
| Ethicon US, LLC | $35.00 | 2021 | |
| Therapeuticsmd, INC. | $22.54 | 2020 | |
| Baxter Healthcare | $20.32 | 2020 | |
| Alexion Pharmaceuticals, INC. | $20.12 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $19.95 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.46 | 2021 | |
| Roche Diagnostics Corporation | $18.89 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.05 | 2019 | |
| Allergan, INC. | $13.81 | 2019 | |
| Boston Scientific Corporation | $13.02 | 2019 | |
| Dysis Medical, INC. | $12.84 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.